Sociedad Quimica y Minera de Chile SA (SQM-B):企業の財務・戦略的SWOT分析

◆英語タイトル:Sociedad Quimica y Minera de Chile SA (SQM-B) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C4901
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:チリ
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sociedad Quimica y Minera de Chile SA (SQM-B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sociedad Quimica y Minera de Chile SA (SQM) is a non-metallic mining company. It carries out the extraction of minerals, capable of integrated in the processing and commercialization of products for essential industries. The company mines and process caliche ore and brine deposits in northern Chile. Its product portfolio includes potassium nitrate, specialty plant nutrients, iodine and its derivatives, lithium and its derivatives, potassium chloride, potassium sulfate and certain industrial chemicals, including industrial nitrates and solar salts. SQM sells products worldwide through a network of representative offices and distribution affiliates. The company has operations in North America, Asia, Europe, and Central and South America. SQM is headquartered in Santiago, Chile.

Sociedad Quimica y Minera de Chile SA Key Recent Developments

Sep 05,2018: Mining deals: Exclusive league tables of financial and legal advisers revealed
Aug 27,2018: SQM tips lithium prices to fall on surging Australian exports
Aug 23,2018: Chilean authorities limit water permits amid severe drought
Aug 22,2018: SQM Reports Earnings for the Second Quarter of 2018
Aug 21,2018: Lake Resources announces operations update on Cauchari Lithium Brine Project

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Sociedad Quimica y Minera de Chile SA – Key Facts 6
Sociedad Quimica y Minera de Chile SA – Key Employees 7
Sociedad Quimica y Minera de Chile SA – Key Employee Biographies 8
Sociedad Quimica y Minera de Chile SA – Major Products and Services 9
Sociedad Quimica y Minera de Chile SA – History 10
Sociedad Quimica y Minera de Chile SA – Company Statement 13
Sociedad Quimica y Minera de Chile SA – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Section 2 – Company Analysis 18
Company Overview 18
Sociedad Quimica y Minera de Chile SA – Business Description 19
Business Segment: Industrial Chemicals 19
Overview 19
Performance 19
Key Stats 19
Business Segment: Iodine and Derivatives 19
Overview 19
Performance 19
Key Stats 20
Business Segment: Lithium and Derivatives 20
Overview 20
Performance 20
Key Stats 20
Business Segment: Other Products and Services 20
Overview 20
Performance 20
Business Segment: Potassium 20
Overview 20
Performance 21
Key Stats 21
Business Segment: Specialty Plant Nutrients 21
Overview 21
Performance 21
Key Stats 21
Geographical Segment: Asia and Others 22
Performance 22
Geographical Segment: Chile 22
Performance 22
Geographical Segment: Europe 22
Performance 22
Geographical Segment: Latin America and the Caribbean 22
Performance 22
Geographical Segment: North America 22
Performance 22
Sociedad Quimica y Minera de Chile SA – Corporate Strategy 23
Sociedad Quimica y Minera de Chile SA – SWOT Analysis 24
SWOT Analysis – Overview 24
Sociedad Quimica y Minera de Chile SA – Strengths 24
Sociedad Quimica y Minera de Chile SA – Weaknesses 25
Sociedad Quimica y Minera de Chile SA – Opportunities 26
Sociedad Quimica y Minera de Chile SA – Threats 27
Sociedad Quimica y Minera de Chile SA – Key Competitors 28
Section 3 – Company Financial Ratios 29
Financial Ratios – Capital Market Ratios 29
Financial Ratios – Annual Ratios 30
Performance Chart 33
Financial Performance 33
Financial Ratios – Interim Ratios 34
Financial Ratios – Ratio Charts 35
Sociedad Quimica y Minera de Chile SA, Recent Deals Summary 36
Section 4 – Company’s Recent Developments 37
Sep 05, 2018: Mining deals: Exclusive league tables of financial and legal advisers revealed 37
Aug 22, 2018: SQM Reports Earnings for the Second Quarter of 2018 38
Aug 16, 2018: SQM Potasio to sell entire stake in Minera Exar to Ganfeng for $87.5m 41
Aug 16, 2018: SQM Potasio to sell entire stake in Minera Exar to Ganfeng for $87.5m 42
Aug 16, 2018: SQM Potasio to sell entire stake in Minera Exar to Ganfeng for $87.5m 43
Jul 20, 2018: SQM seeks Chile Government approval for $450m lithium plant expansion 44
May 23, 2018: SQM Reports Earnings for the First Quarter of 2018 45
Apr 30, 2018: SQM Announces End of Controller Group Agreement 48
Feb 19, 2018: SQM announces Board Member nomination 49
Dec 05, 2017: Tesla Completes World’s Largest Lithium Battery Ahead of Schedule 50
Section 5 – Appendix 51
Methodology 51
Ratio Definitions 51
About GlobalData 55
Contact Us 55
Disclaimer 55

List of Tables
Sociedad Quimica y Minera de Chile SA, Key Facts 6
Sociedad Quimica y Minera de Chile SA, Key Employees 7
Sociedad Quimica y Minera de Chile SA, Key Employee Biographies 8
Sociedad Quimica y Minera de Chile SA, Major Products and Services 9
Sociedad Quimica y Minera de Chile SA, History 10
Sociedad Quimica y Minera de Chile SA, Subsidiaries 16
Sociedad Quimica y Minera de Chile SA, Key Competitors 28
Sociedad Quimica y Minera de Chile SA, Ratios based on current share price 29
Sociedad Quimica y Minera de Chile SA, Annual Ratios 30
Sociedad Quimica y Minera de Chile SA, Annual Ratios (Cont...1) 31
Sociedad Quimica y Minera de Chile SA, Annual Ratios (Cont...2) 32
Sociedad Quimica y Minera de Chile SA, Interim Ratios 34
Sociedad Quimica y Minera de Chile SA, Recent Deals Summary 36
Currency Codes 51
Capital Market Ratios 51
Equity Ratios 52
Profitability Ratios 52
Cost Ratios 53
Liquidity Ratios 53
Leverage Ratios 54
Efficiency Ratios 54

List of Figures
Sociedad Quimica y Minera de Chile SA, Performance Chart (2013 - 2017) 33
Sociedad Quimica y Minera de Chile SA, Ratio Charts 35

★海外企業調査レポート[Sociedad Quimica y Minera de Chile SA (SQM-B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GNI Group Ltd (2160):製薬・医療:M&Aディール及び事業提携情報
    Summary GNI Group Ltd (GNI) is a healthcare service provider that researches, develops, manufactures and markets pharmaceutical drugs. The company’s business operations consist of drug discovery activities such as drug discovery research, drug discovery infrastructure, fundamental drug discovery, an …
  • Celltrion Inc (068270):企業の財務・戦略的SWOT分析
    Celltrion Inc (068270) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Amazon Web Services Inc:企業の戦略・SWOT・財務分析
    Amazon Web Services Inc - Strategy, SWOT and Corporate Finance Report Summary Amazon Web Services Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Landauer Inc (LDR):企業の財務・戦略的SWOT分析
    Summary Landauer Inc (Landauer), a subsidiary of Fortive Corp, is a medical device company that manufactures and distributes integrated radiation safety products. The company provides professional medical physics, occupational radiation monitoring, and medical products. Its products include dosimete …
  • Atlas Copco AB (ATCO A)-石油・ガス分野:企業M&A・提携分析
    Summary Atlas Copco AB (Atlas Copco) is an industrial productivity solutions provider. It develops and manufactures vacuum solutions, air treatment systems, compressors, assembly systems, construction and mining equipment, and power tools. Its product portfolio includes air and gas compressors, mach …
  • JFE Holdings Inc (5411):企業の財務・戦略的SWOT分析
    JFE Holdings Inc (5411) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Milliken & Co:企業の戦略的SWOT分析
    Milliken & Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Ekarat Engineering (Public) Co Ltd (AKR):企業の財務・戦略的SWOT分析
    Ekarat Engineering (Public) Co Ltd (AKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Martin Midstream Partners L.P.:企業のM&A・事業提携・投資動向
    Martin Midstream Partners L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Martin Midstream Partners L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • PT Central Proteina Prima Tbk (CPRO):企業の財務・戦略的SWOT分析
    PT Central Proteina Prima Tbk (CPRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Telkom SA SOC Limited:企業の戦略・SWOT・財務分析
    Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report Summary Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ferring International Center SA:企業の戦略的SWOT分析
    Ferring International Center SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Imperial Brands Plc:企業の戦略・SWOT・財務情報
    Imperial Brands Plc - Strategy, SWOT and Corporate Finance Report Summary Imperial Brands Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Gruma, S.A.B. de C.V.:企業の戦略・SWOT・財務情報
    Gruma, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Gruma, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Gannett Co., Inc.:戦略・SWOT・企業財務分析
    Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Bri-Chem Corp. (BRY):石油・ガス:M&Aディール及び事業提携情報
    Summary Bri-Chem Corp (Bri-Chem) is an oil and gas drilling fluids provider. It manufactures, blends, packs and conducts wholesale distribution of oilfield drilling, completion, stimulation and production chemical fluids. The company supplies custom blended cementing, acidizing and fracturing chemic …
  • Ana Holdings Inc:企業の戦略・SWOT・財務分析
    Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • MagForce AG (MF6):企業の財務・戦略的SWOT分析
    Summary MagForce AG (MagForce) is a medical device company that offers nanotechnology-based therapy for cancer treatment. The company’s products include NanoActivator, NanoTherm, NanoPlan and NanoTherm Therapy. Its NanoActivator creates a magnetic field that can be used to treat tumors in all areas …
  • ContraVir Pharmaceuticals Inc (CTRV):製薬・医療:M&Aディール及び事業提携情報
    Summary ContraVir Pharmaceuticals Inc (ContraVir) is a biopharmaceutical company that offers development and commercialization of targeted antiviral therapies. The company provides pipeline product such as TXL, potent prodrug of antiviral tenofovir and CRV431 cyclophilin inhibitor that increases its …
  • Alfred E. Tiefenbacher (GmbH & Co KG)-製薬・医療分野:企業M&A・提携分析
    Summary Alfred E. Tiefenbacher (GmbH & Co KG) (AET) is a healthcare products provider that develops active pharmaceuticals ingredients. The company’s products comprise cytotoxic drugs, hormones, OTC drugs, controlled drugs, herbal drugs, high potent drugs, new combination products, inhaler technolog …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆